Le Lézard
Classified in: Health, Business
Subject: CON

Paradigm Treatment Announces Anthem Blue Cross Now In Network


LOS ANGELES, July 28, 2021 /PRNewswire/ -- Paradigm Treatment the leading treatment center in California helping teens and young adults ages 12-26 with mental health issues for over 10 years today announces a new in-network contract. Beginning August 5, Paradigm will begin welcoming members of Anthem Blue Cross.

Paradigm Treatment Announces Anthem Blue Cross Now In Network

The new contract with Anthem Blue Cross covers mental health residential and telehealth treatment for teens 12-17 and young adults 18-26 across all of Paradigm's 7 California locations. Treatment at Paradigm is accredited by The Joint Commission, the gold standard in treatment accreditation.

"We could not be more excited to be partnering with Anthem Blue Cross. It's an agreement that is a long time in the making and which will allow Paradigm to provide our proven, high quality mental health treatment services to more teens and young adults than ever before," said Paul Auchterlonie, Paradigm's CEO. "Given the pandemic of mental illness amongst young people that has been created in the wake of the COVID crisis, this agreement with Anthem Blue Cross will enhance our ability to serve individuals and families in need," continued Auchterlonie.

"We look forward to building a strong collaborative relationship with Paradigm and helping improve the health of our communities," stated Evelyn Umana, Anthem Provider Network Manager II.

With the new contract going into effect August 5, 2021, Paradigm's in-network partners will include Anthem Blue Cross, Managed Health Network (MHN/Healthnet), and Kaiser.

For details on Paradigm's in-network contracts, please call (887) 883-1223.

About Paradigm

Paradigm Treatment with 7 locations in San Rafael and in Malibu has been helping teens and young adults ages 12-26 with mental health issues for over 10 years. Paradigm's medical and clinical teams delve deep to address the root causes of many mental health conditions including anxiety, depression, bipolar, grief, trauma, mood and personality disorders and co-occurring substance use. Help is a phone call away 877-883-1223  https://paradigmtreatment.com/

Contact: Annmarie Seldon

AMS Communications

617-448-7416  

SOURCE Paradigm Treatment


These press releases may also interest you

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...



News published on and distributed by: